Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Guomai Culture & Media
301052
4
WuHan Hvsen Biotechnology
300871
5
CHANGFU CO.,LTD
871396
CN Stock MarketDetailed Quotes
600062 China Resources Double-Crane Pharmaceutical
- 18.91
- -0.18-0.94%
Not Open Mar 28 15:00 CST
19.64BMarket Cap12.07P/E (TTM)
19.33High18.91Low119.82KlotVolume19.09Open19.09Pre Close229.08MTurnover1.17%Turnover Ratio12.07P/E (Static)1.04BShares26.0552wk High1.89P/B19.42BFloat Cap17.0952wk Low21.00Limit Up1.03BShs Float36.03Historical High17.18Limit Down2.20%Amplitude-1.85Historical Low0.36Dividend TTM19.12Avg Price64.16KlotAsk1.89%Div YieldTTM100Lot Size52.49KlotBid
China Resources Double-Crane Pharmaceutical Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -17.65%2.85B | -8.64%2.71B | -6.85%2.27B | 48.88%3.65B | 31.61%3.46B | 9.45%2.96B | -32.13%2.44B | -9.69%2.45B | -7.18%2.63B | 8.36%2.71B |
| Transactional financial assets | ---- | ---- | ---- | ---- | ---- | -0.29%400.95M | 696.01%802.76M | -50.07%401.77M | -75.05%200.49M | -58.04%402.13M |
| Notes receivable and accounts receivable | 2.08%1.76B | 20.06%2.01B | 16.85%2.11B | 8.41%1.84B | 28.68%1.73B | 1.05%1.68B | 8.87%1.81B | 13.60%1.7B | 8.96%1.34B | 14.31%1.66B |
| -Accounts receivable | 2.08%1.76B | 20.06%2.01B | 16.85%2.11B | 8.41%1.84B | 28.68%1.73B | 1.05%1.68B | 8.87%1.81B | 13.60%1.7B | 8.96%1.34B | 14.31%1.66B |
| Other receivables (including interest and dividends) | -86.34%183.88M | 25.92%59.83M | 59.38%57.88M | 17.46%42.89M | 219.67%1.35B | 62.75%47.51M | 29.02%36.31M | 30.55%36.52M | 1,897.70%421.11M | -30.41%29.19M |
| -Dividend receivable | --94.49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other receivable | -93.36%89.39M | ---- | 59.38%57.88M | ---- | 219.67%1.35B | ---- | 29.02%36.31M | ---- | 1,897.70%421.11M | ---- |
| Advance payment | -24.60%151.81M | 18.87%259.98M | 13.13%243.85M | 22.79%196M | 10.52%201.34M | 9.26%218.71M | 22.85%215.55M | 5.48%159.63M | 42.61%182.17M | 33.35%200.17M |
| Inventories | -5.55%1.59B | -8.63%1.54B | -15.42%1.58B | -29.35%1.37B | -11.19%1.69B | -4.96%1.68B | 22.85%1.87B | 24.88%1.94B | 14.10%1.9B | 11.40%1.77B |
| Receivable financing | -7.94%832.9M | 15.50%642.76M | 56.28%786.59M | 5.90%727.21M | 4.32%904.73M | -7.20%556.5M | 13.58%503.33M | 2.78%686.69M | 16.37%867.25M | -7.69%599.66M |
| Non-current assets due within one year | -89.37%925K | -3.77%9.62M | -3.77%9.62M | -13.02%8.7M | -13.02%8.7M | 0.00%10M | 0.00%10M | 0.00%10M | 0.00%10M | --10M |
| Other current assets | 131.03%97.93M | 559.92%53.94M | 692.41%76.51M | -47.65%28.41M | -49.29%42.39M | -68.96%8.17M | -83.62%9.66M | 15.56%54.27M | 1.36%83.59M | 50.39%26.33M |
| Total current assets | -20.30%7.48B | -3.71%7.28B | -7.21%7.14B | 5.71%7.87B | 22.81%9.38B | 2.16%7.56B | 1.33%7.7B | -0.44%7.44B | 1.54%7.64B | 0.65%7.4B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -20.31%12M | 0.97%14.36M | -5.53%14.36M | -9.34%14.76M | -12.02%15.06M | -10.67%14.22M | -20.33%15.2M | -17.57%16.28M | -13.33%17.11M | -19.39%15.92M |
| Investment real estate | -0.26%79.44M | 66.67%78.5M | 62.81%77.75M | 7.54%46.52M | 81.54%79.65M | 5.86%47.1M | 5.88%47.76M | -5.40%43.25M | 11.76%43.87M | 11.72%44.49M |
| Long-term equity investment | 3.56%1.04B | 230.53%1.1B | 214.93%1.06B | 5.12%354.34M | 200.32%1B | -1.95%333.55M | 0.40%335.16M | 18.78%337.07M | 17.45%333.17M | 21.24%340.19M |
| Long term receivable account | --2.37M | -67.13%2.57M | -64.63%2.76M | ---- | ---- | -52.63%7.81M | -52.63%7.81M | -52.63%7.81M | -52.63%7.81M | -57.88%16.48M |
| Fixed assets | 9.68%3.75B | ---- | 24.67%3.72B | ---- | 11.20%3.42B | ---- | 15.55%2.98B | ---- | 16.96%3.08B | ---- |
| Constru in process | -20.20%455.14M | ---- | -31.76%366.18M | ---- | 29.71%570.38M | ---- | 49.05%536.63M | ---- | 61.18%439.72M | ---- |
| Intangible assets | -1.08%1.75B | 30.42%1.97B | 17.01%1.73B | 13.05%1.7B | 7.28%1.77B | -0.63%1.51B | 16.85%1.48B | 24.85%1.51B | 38.17%1.65B | 28.99%1.52B |
| Development expenditure | -8.36%724.74M | -5.44%746.01M | -8.74%774.78M | -2.42%760.36M | 2.45%790.89M | 11.86%788.91M | 19.10%849.02M | 1.80%779.24M | 9.23%771.96M | 18.65%705.28M |
| Goodwill | -3.24%878.49M | -2.89%907.9M | -2.89%907.9M | -3.09%906.06M | -2.89%907.9M | 0.08%934.96M | 18.62%934.96M | 18.62%934.96M | 18.62%934.96M | 10.58%934.24M |
| Long deferred expense | -8.76%20.18M | 22.56%21.24M | 23.91%22.73M | 21.31%23.61M | 8.73%22.11M | 1.53%17.33M | 13.82%18.34M | 15.39%19.46M | 20.18%20.34M | 2.01%17.07M |
| Deferred tax assets | -3.40%135.8M | 15.66%129.36M | 19.81%133.62M | -1.10%112.24M | 10.52%140.58M | 37.80%111.84M | 82.62%111.53M | 84.78%113.49M | 72.42%127.19M | 60.13%81.16M |
| Usufruct assets | -43.05%31.48M | -19.76%40.32M | -15.28%45.14M | -12.65%51.42M | 0.45%55.27M | -9.93%50.25M | -7.53%53.28M | -6.14%58.87M | 0.84%55.03M | -30.22%55.79M |
| Other non current assets | 563.90%332.96M | 202.41%133.13M | 98.77%111.21M | 34.79%48.38M | -2.79%50.15M | -44.66%44.02M | -21.02%55.95M | -42.37%35.89M | -12.36%51.59M | 32.91%79.55M |
| Total non current assets | 4.40%9.21B | 23.76%9.26B | 20.65%8.96B | 6.83%7.81B | 17.20%8.82B | 3.57%7.48B | 17.37%7.43B | 17.22%7.31B | 22.31%7.53B | 19.89%7.23B |
| Total assets | -8.33%16.69B | 9.95%16.55B | 6.47%16.11B | 6.26%15.68B | 20.03%18.2B | 2.86%15.05B | 8.62%15.13B | 7.59%14.75B | 10.89%15.17B | 9.31%14.63B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 112.06%63.55M | 341.47%65.55M | 549.42%73.88M | 437.42%36.68M | 505.92%29.97M | 316.64%14.85M | --11.38M | 10.21%6.83M | 4.24%4.95M | 52.94%3.56M |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.17M |
| Notes payable and accounts payable | 12.87%835.81M | 2.31%722.74M | -0.82%797.05M | -18.89%656.73M | -1.32%740.49M | -8.60%706.4M | 22.76%803.66M | 10.24%809.71M | -11.45%750.39M | -8.62%772.9M |
| -Notes payable | -24.89%19.39M | -2.81%24.27M | -7.88%21.57M | -1.42%19.83M | 35.30%25.82M | -7.12%24.97M | 4.80%23.42M | 282.89%20.11M | 34.21%19.08M | 86.15%26.89M |
| -Accounts payable | 14.24%816.42M | 2.50%698.46M | -0.61%775.48M | -19.34%636.9M | -2.28%714.67M | -8.66%681.42M | 23.39%780.25M | 8.27%789.59M | -12.23%731.31M | -10.27%746.01M |
| Contract liabilities | -40.40%174.88M | 84.11%233.71M | 91.71%286.51M | 7.65%136.77M | 51.09%293.43M | -43.08%126.94M | -31.84%149.45M | -49.82%127.04M | -3.55%194.21M | 66.71%223M |
| Salaries payable | 5.41%484.02M | 46.28%426.87M | 43.14%384.3M | 4.16%232.09M | 32.47%459.17M | 6.41%291.81M | 8.00%268.48M | 42.85%222.84M | 31.92%346.63M | 28.49%274.25M |
| Taxs payable | -15.62%123.04M | -1.68%153.88M | -1.51%147.65M | -29.32%141.58M | -31.16%145.82M | -30.56%156.5M | -30.10%149.92M | 16.82%200.3M | 52.56%211.83M | 77.71%225.39M |
| Other payable (including interest and dividends) | -20.21%2.28B | 101.82%2.92B | 87.84%3.14B | 8.07%1.58B | 91.51%2.85B | -12.48%1.45B | 7.97%1.67B | 11.63%1.46B | 24.78%1.49B | 55.64%1.65B |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --266.67K |
| -Dividend payable | -84.62%200M | 123.35%403.93M | 88.73%567.11M | ---- | --1.3B | -62.42%180.85M | -1.54%300.48M | 22.36%6.41M | ---- | --481.24M |
| -Other payable | 33.70%2.08B | ---- | 87.64%2.58B | ---- | 4.25%1.55B | ---- | 10.30%1.37B | ---- | 24.78%1.49B | --1.17B |
| Non current liabilities due within one year | -86.08%32.19M | -90.28%20.97M | -90.04%22.87M | 83,518.22%222.98M | 753.08%231.3M | 3,033.83%215.8M | 796.40%229.69M | -96.13%266.67K | 9.66%27.11M | 3.78%6.89M |
| Other current liabilities | -50.19%12.92M | 24.60%24.21M | -65.70%26.28M | -78.89%12.08M | -54.96%25.93M | -90.78%19.43M | 33.96%76.63M | 0.00%57.2M | 0.65%57.58M | 380.06%210.8M |
| Total current liabilities | -16.25%4B | 53.36%4.57B | 45.17%4.88B | 4.60%3.02B | 55.04%4.78B | -11.65%2.98B | 13.06%3.36B | 7.08%2.88B | 12.87%3.08B | 38.45%3.37B |
| Current liabilities | ||||||||||
| Long term loan | --1.09B | --599.91M | --100.16M | ---- | ---- | ---- | ---- | --200M | --200M | --200M |
| Long term account payable | 0.00%4M | ---- | --4M | ---- | --4M | ---- | --0 | ---- | --0 | ---- |
| Long term salaries pay | 14.97%169.64M | 1.46%146.94M | 1.80%147.32M | -24.59%108.51M | 2.33%147.55M | -8.63%144.82M | -8.59%144.71M | -8.54%143.9M | -8.60%144.18M | 4.93%158.5M |
| Specific account payable | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%545.99K | ---- | 0.00%545.99K | ---- |
| Estimate liabilities | 0.00%1.67M | 0.00%1.67M | -64.28%1.67M | -64.28%1.67M | -64.28%1.67M | -64.28%1.67M | 557.76%4.67M | 557.76%4.67M | 557.76%4.67M | 557.76%4.67M |
| Deferred tax liabilities | -22.06%123.6M | -0.87%147.6M | 2.50%151.61M | -8.06%142.6M | -9.98%158.59M | 14.52%148.9M | 27.12%147.91M | 32.24%155.11M | 46.39%176.17M | 6.03%130.03M |
| Long term deferred income | -11.87%160.67M | -13.79%163.49M | -13.34%169.49M | -9.42%174.26M | -8.60%182.31M | -1.42%189.65M | 30.12%195.58M | 30.85%192.39M | 29.71%199.46M | 65.99%192.38M |
| Lease liabilities | -26.22%22.1M | -36.46%25.08M | -0.45%29.31M | -43.90%31.67M | -9.06%29.95M | -26.33%39.47M | -20.01%29.44M | -8.80%56.45M | -7.06%32.93M | -48.86%53.57M |
| Total non current liabilities | 199.86%1.57B | 107.35%1.09B | 15.43%603.55M | -39.09%458.71M | -30.86%524.06M | -29.02%525.05M | 12.92%522.86M | 55.33%753.06M | 61.76%757.96M | 45.35%739.7M |
| Total liabilities | 5.11%5.57B | 61.45%5.66B | 41.17%5.48B | -4.45%3.48B | 38.09%5.3B | -14.77%3.5B | 13.04%3.88B | 14.44%3.64B | 20.03%3.84B | 39.64%4.11B |
| Shareholders equity | ||||||||||
| Paid-in capital | -0.08%1.04B | -0.04%1.04B | -0.33%1.04B | -0.33%1.04B | -0.33%1.04B | -0.34%1.04B | -0.01%1.04B | -0.01%1.04B | -0.01%1.04B | 0.00%1.04B |
| Capital reserve funds | -76.90%193.45M | 24.97%190.39M | 30.48%181.99M | 36.53%173.59M | 204.32%837.55M | -6.85%152.34M | -22.22%139.47M | -14.89%127.14M | 84.23%275.22M | 9.47%163.54M |
| Surplus reserve funds | -92.88%24.21M | ---- | ---- | -29.30%340.17M | -29.30%340.17M | -15.68%439.84M | -7.76%481.15M | -7.76%481.15M | -7.76%481.15M | 0.00%521.62M |
| Retained profit | -8.65%9.24B | -3.17%9.04B | -2.67%8.8B | 12.91%10.09B | 13.28%10.12B | 11.49%9.34B | 7.15%9.04B | 4.75%8.93B | 9.00%8.93B | 2.77%8.38B |
| Less:Treasury stock | -40.78%74.36M | -35.76%80.62M | -48.59%87.36M | -28.53%125.56M | -28.53%125.56M | -55.33%125.5M | -39.51%169.93M | -37.46%175.68M | --175.68M | --280.92M |
| Other composite income | -339.53%-30.47M | 11.11%-6.12M | -0.77%-6.93M | 11.19%-6.12M | 0.57%-6.93M | 21.76%-6.88M | 21.82%-6.88M | 21.80%-6.89M | 20.82%-6.97M | -289.24%-8.8M |
| Specific reserves | 35.39%11.17M | -1.95%8.57M | 40.74%10.75M | 11.77%7.28M | 48.99%8.25M | 70.37%8.74M | 79.09%7.64M | 87.77%6.51M | 52.21%5.54M | 29.94%5.13M |
| Shareholders equity without minority interests | -14.78%10.41B | -6.02%10.19B | -5.67%9.93B | 10.64%11.52B | 15.70%12.21B | 10.46%10.85B | 6.46%10.53B | 4.54%10.41B | 6.57%10.56B | -0.47%9.82B |
| Minority interests | 2.61%703.89M | -0.35%695.01M | -3.20%687.26M | -2.98%688.12M | -10.74%685.95M | -0.22%697.43M | 18.93%710M | 22.46%709.28M | 34.57%768.46M | 21.90%698.97M |
| Other items effecting shareholder equity | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- |
| Total shareholder equity | -13.86%11.11B | -5.68%10.89B | -5.52%10.62B | 9.77%12.2B | 13.90%12.9B | 9.75%11.54B | 7.17%11.24B | 5.53%11.12B | 8.10%11.32B | 0.76%10.52B |
| Total liabilityies and equity | -8.33%16.69B | 9.95%16.55B | 6.47%16.11B | 6.26%15.68B | 20.03%18.2B | 2.86%15.05B | 8.62%15.13B | 7.59%14.75B | 10.89%15.17B | 9.31%14.63B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.